Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q27001770)
Watch
English
Clinical trial methodologies for disease-modifying therapeutic approaches
scientific article
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
PubMed
review article
1 reference
stated in
Europe PubMed Central
title
Clinical trial methodologies for disease-modifying therapeutic approaches
(English)
0 references
author
Paul S. Aisen
series ordinal
1
object named as
Paul S. Aisen
1 reference
stated in
Crossref
language of work or name
English
1 reference
stated in
PubMed
publication date
December 2011
1 reference
stated in
PubMed
published in
Neurobiology of Aging
1 reference
stated in
PubMed
volume
32 Suppl 1
1 reference
stated in
PubMed
page(s)
S64-6
1 reference
stated in
PubMed
cites work
Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232303
retrieved
21 March 2017
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232303
retrieved
7 April 2017
Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232303
retrieved
28 September 2017
11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232303
retrieved
28 September 2017
Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232303
retrieved
28 September 2017
Alzheimer's disease therapeutic research: the path forward
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232303
retrieved
28 September 2017
A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232303
retrieved
28 September 2017
Safety and changes in plasma and cerebrospinal fluid amyloid beta after a single administration of an amyloid beta monoclonal antibody in subjects with Alzheimer disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232303
retrieved
28 November 2018
Identifiers
DOI
10.1016/J.NEUROBIOLAGING.2011.09.008
0 references
Fatcat ID
release_74wnwko7zzcnrcy6oivlkesmg4
1 reference
stated in
Fatcat
reference URL
https://api.fatcat.wiki/v0/release/74wnwko7zzcnrcy6oivlkesmg4
retrieved
24 November 2022
based on heuristic
mapped directly with Wikidata item
PMC publication ID
3232303
0 references
PubMed publication ID
21983242
1 reference
stated in
PubMed
ResearchGate publication ID
51702832
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
